Pacira Biosciences Inc (NASDAQ:PCRX)
| 60.08 BATS BZX Real-Time Price As of 1:33pm ET |  -0.72 / -1.18%Today’s Change | 42.67 Today|||52-Week Range 80.00 | +0.40% Year-to-Date |
Latest PCRX News | Press Releases
| Moving Average Crossover Alert: Pacira BioSciences (PCRX) Jun 15 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 60.80 |
| Today’s open | 60.62 |
| Day’s range | 59.37 - 61.00 |
| Volume | 11,074 |
| Average volume (3 months) | 450,497 |
| Market cap | $2.7B |
Data as of 1:33pm ET, 06/17/2021
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +32.89% |
| Earnings growth (next 5 years) | +24.70% |
| Revenue growth (last year) | +2.05% |
| P/E ratio | 17.8 |
| Price/Sales | 6.08 |
| Price/Book | 4.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PTCTPTC Therapeutics Inc | -0.59 | -1.33% |
| TAROTaro Pharmaceutical ... | +0.13 | +0.17% |
| INSMInsmed Inc | +0.05 | +0.17% |
| FOLDAmicus Therapeutics ... | -0.12 | -1.19% |
Data as of 1:37pm ET, 06/17/2021
Financials
| Next reporting date | August 5, 2021 |
| EPS forecast (this quarter) | $0.68 |
| Annual revenue (last year) | $429.6M |
| Annual profit (last year) | $145.5M |
| Net profit margin | 33.87% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Parsippany, New Jersey |
Forecasts
